FDA Issues Warning letter to Chinese API
FDA issued Warning letter to two Chinese API manufacturers following for cGMP violations including failing
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
